Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results